JP2023516153A5 - - Google Patents

Info

Publication number
JP2023516153A5
JP2023516153A5 JP2022551024A JP2022551024A JP2023516153A5 JP 2023516153 A5 JP2023516153 A5 JP 2023516153A5 JP 2022551024 A JP2022551024 A JP 2022551024A JP 2022551024 A JP2022551024 A JP 2022551024A JP 2023516153 A5 JP2023516153 A5 JP 2023516153A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
asc
composition
change
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022551024A
Other languages
English (en)
Japanese (ja)
Other versions
JP7840859B2 (ja
JP2023516153A (ja
Filing date
Publication date
Priority claimed from EP20160817.1A external-priority patent/EP3875083A1/en
Application filed filed Critical
Publication of JP2023516153A publication Critical patent/JP2023516153A/ja
Publication of JP2023516153A5 publication Critical patent/JP2023516153A5/ja
Application granted granted Critical
Publication of JP7840859B2 publication Critical patent/JP7840859B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022551024A 2020-03-03 2021-03-03 子宮頸部細胞異常の治療に使用するための組成物 Active JP7840859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20160817.1 2020-03-03
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
PCT/EP2021/055230 WO2021175877A1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (3)

Publication Number Publication Date
JP2023516153A JP2023516153A (ja) 2023-04-18
JP2023516153A5 true JP2023516153A5 (https=) 2026-03-16
JP7840859B2 JP7840859B2 (ja) 2026-04-06

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022551024A Active JP7840859B2 (ja) 2020-03-03 2021-03-03 子宮頸部細胞異常の治療に使用するための組成物

Country Status (23)

Country Link
US (1) US20230092142A1 (https=)
EP (2) EP3875083A1 (https=)
JP (1) JP7840859B2 (https=)
CN (1) CN115279358A (https=)
AR (1) AR122387A1 (https=)
AU (1) AU2021231205B2 (https=)
BR (1) BR112022017436A2 (https=)
CL (1) CL2022002363A1 (https=)
CY (1) CY1126764T1 (https=)
ES (1) ES2976058T3 (https=)
HR (1) HRP20240374T1 (https=)
HU (1) HUE066384T2 (https=)
IL (1) IL296146A (https=)
MA (1) MA58262B1 (https=)
MD (1) MD4084788T2 (https=)
MX (1) MX2022010838A (https=)
PL (1) PL4084788T3 (https=)
RS (1) RS65349B1 (https=)
SM (1) SMT202400126T1 (https=)
TW (1) TW202146004A (https=)
UA (1) UA130108C2 (https=)
WO (1) WO2021175877A1 (https=)
ZA (1) ZA202208848B (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Similar Documents

Publication Publication Date Title
JP2006512413A5 (https=)
JP2021525266A5 (https=)
JP2021536454A5 (https=)
CN107582563B (zh) 用于治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂
JP2023516153A5 (https=)
ES2958808T3 (es) Terapia de infecciones por virus del papiloma humano de alto riesgo
IL296146A (en) Preparations containing compounds containing selenite for use in the treatment of cervical cell abnormalities
TWI905319B (zh) Arb代謝產物與nep抑制劑的複合物在製備用於預防和/或治療腎病的藥物中的用途
CN104771384A (zh) 紫草素的医药用途
CA3167015C (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
Nuyts Role of vaccination in oropharyngeal cancer prevention
Arab A Gynecological Oncovirus: HPV and Cervical Cancer
WO2026059487A1 (en) The use of pokeweed antiviral protein isoform one (pap-i) for the treatment of human papilloma virus (hpv) infection and hpv-associated diseases
CN117224539A (zh) 苯并咪唑类化合物在制备预防或治疗hpv感染的药物中的应用
EA042677B1 (ru) Терапия папилломавирусных инфекций человека высокого риска
HK40045218A (en) Therapy of high-risk human papillomavirus infections
HK40045218B (en) Therapy of high-risk human papillomavirus infections
WO2015161479A1 (zh) 一种嘧啶类化合物的抗宫颈癌用途
CN104825623A (zh) 一种中药组合物在制备治疗急性鼻咽炎的药物中的应用
HK40074763A (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
HK40074763B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
Bala et al. CERVICAL CANCER: DISEASE AND ITS PATHOLOGY
EA048159B1 (ru) Композиция для применения в лечении аномалий цервикальных клеток, содержащая селенитовое соединение и кислоту
HK1243360B (zh) 用於治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂